Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Cytogenetics and Cell Genetics
|
January 1, 1993
Detection of human chromosomes in somatic cell hybrids by PCR analysis
P Tripputi, G Bacciocchi, R S Accolla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1992
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules
F Arienti, C Gambacorti-Passerini, L Borin, et al.
Gene
|
January 30, 1993
Molecular organization and chromosomal location of human GC-rich heterochromatic blocks
R Meneveri, A Agresti, A Marozzi, et al.
Leukemia
|
February 1, 1993
Human T-cell lymphoblastic lymphoma expressing the T-cell receptor gamma/delta established in immune-deficient (bg/nu/xid) mice
A Biondi, T Motta, A Garofalo, et al.
Tumori
|
July 1, 1995
Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up
E M Pogliani, F Rossini, I Miccolis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1994
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors
F Rossini, P Pioltelli, S Mingozzi, et al.
Leukemia & Lymphoma
|
September 1, 1993
Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcome
R Bassan, R Battista, G Corneo, et al.
Leukemia & Lymphoma
|
June 1, 1997
Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs
R Bassan, T Lerede, E Di Bona, et al.
Leukemia
|
August 27, 2005
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients
R G Piazza, V Magistroni, F Andreoni, et al.
British Journal of Haematology
|
April 7, 1999
Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia
R Bassan, T Lerede, E Di Bona, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Cytogenetics and Cell Genetics
|
January 1, 1993
Detection of human chromosomes in somatic cell hybrids by PCR analysis
P Tripputi, G Bacciocchi, R S Accolla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1992
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules
F Arienti, C Gambacorti-Passerini, L Borin, et al.
Gene
|
January 30, 1993
Molecular organization and chromosomal location of human GC-rich heterochromatic blocks
R Meneveri, A Agresti, A Marozzi, et al.
Leukemia
|
February 1, 1993
Human T-cell lymphoblastic lymphoma expressing the T-cell receptor gamma/delta established in immune-deficient (bg/nu/xid) mice
A Biondi, T Motta, A Garofalo, et al.
Tumori
|
July 1, 1995
Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up
E M Pogliani, F Rossini, I Miccolis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1994
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors
F Rossini, P Pioltelli, S Mingozzi, et al.
Leukemia & Lymphoma
|
September 1, 1993
Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcome
R Bassan, R Battista, G Corneo, et al.
Leukemia & Lymphoma
|
June 1, 1997
Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs
R Bassan, T Lerede, E Di Bona, et al.
Leukemia
|
August 27, 2005
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients
R G Piazza, V Magistroni, F Andreoni, et al.
British Journal of Haematology
|
April 7, 1999
Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia
R Bassan, T Lerede, E Di Bona, et al.
Page
of 8